26 jan: Villa Joy - dansk konceptbolig med verdensinspiration og potentia..
02 feb: Stort behov for mini-MBA i bestyrelsesuddannelse
28-01-2010 08:02:00

Preliminary Annual Accounts / Fourth Quarter Report 2009

This information is subject of the disclosure requirements acc. to §5-12 vphl

(Norwegian Securities Trading Act)

Rieber & Søn's operating profit (EBIT) in the fourth quarter totalled NOK 185m

(122m), while the figure for the year was NOK 424m (356m). EPS in the fourth

quarter stood at  NOK 1.52  (0.82) and NOK 3.32 (2.46) for the year.

Sales in the fourth quarter came to NOK 1 256m (1 377m), while the figure for

the year was NOK 4 967m (4 997m). Structural effects had a negative effect on

sales, reducing the performance by 1.6% in the fourth quarter, and by 0.6% for

the year. Currency conversion effects reduced sales in the fourth quarter by

4.7% and by 0.4% for the year. Organic growth stood at -2.4% in the fourth

quarter, while the increase for the year was 0.4%.

The gross margin in the fourth quarter rose to 59.2% (57.1%) and to 56.7%

(56,0%) for the year. The Group had good cost control in the fourth quarter and

payroll and operating costs were down 8% at NOK 569m, while the figure for the

year was 1% lower at NOK 2 218m. The EBITDA margin for the fourth quarter was

13,9% (12.1%) and 12.1% (11.2%) for the year. The corresponding figures for

 EBIT margin were 14.7% (8.9%) and 8.5% (7.1%), respectively.

The operating profit in the fourth quarter was positively affected by one-off

effects which contributed NOK 61m. This was the net effect of income of NOK 77m

from the sale of the  Sopps brand and the marine ingredients line in Arna, and

costs of NOK 16m related to the write-down of the production plant for Anja Cake

in Poland and transaction costs for the acquisition of Gellwe which was not

approved by the Polish competition authorities.  The operating profit for the

year was positively affected by one-off effects totalling NOK 32m. The Group's

core activities exclusive one-off items provided EPS of NOK 3.09 for the year,

which was 30% up on 2008.

The return on capital employed was 22.7% (14.1%) in the fourth quarters and

12.8% (10.9%) for the year.

In line with the Group's dividend policy, the Board will ask the AGM to approve

a dividend of NOK 2.00 per share. Together, this represents a 60% increase in

the dividend compared with the previous year and a dividend ratio of 60%.

"Our Future"

"Our Future" is aimed at achieving lasting improvements in results of NOK 400m

in 2012. The extra consumption of resources of a one-time nature in order to

realise these improvements is estimated to cost NOK 125m. The programme is

progressing as planned.

In the fourth quarter, the net effect of improvements in purchasing, production

and marketing under the "Our Future" platform totalled NOK 35m and comprised

positive effects of NOK 44m in the fourth quarter and implementation costs of

NOK 9m. The accumulated total of the positive, lasting effects in the first 12

months was NOK 96m, while implementation costs in the same period came to NOK

47m.

The aim to improve Group profitability was achieved in line with the plans for

2009. Through good cost control and the implementation of efficiency programmes

which provide lasting improvements, a sound basis has been laid for further

growth in profitability.

Bergen, 27 January 2010

Board of Directors of Rieber & Søn ASA

[HUG#1377906]

4Q Quarter Report 2009 : http://hugin.info/121/R/1377906/338577.pdf

4Q Presentation 2009: http://hugin.info/121/R/1377906/338578.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
19 maj
 
Hey alle   Jeg har nu handlet aktier siden ca. 5 januar. Det startede med at jeg skulle satse ca. 40..
73
20 maj
 
Kære Moderator og EI   Det vidner lidt om overvågningen af sitet når en gruppe Nordkoreanern kan få ..
41
19 maj
OMXC20CAP
I mit indlæg fra den 20 April : http://www.euroinvestor.dk/debat/post-59413-372203-3659768/rusland-h..
35
24 maj
NOVO-B
Ved godt der er en lang Novo tråd lige nedenfor, men synes Elliot fortjener en selvstændig tråd som ..
25
20 maj
FING-B
Kære Swiftnick,   Jeg har sagt det tidligere, men jeg gentager gerne budskabet. Sä lyt godt efter! D..
24
22 maj
ZEAL
Hvorfor der sker et frasalg har jeg ingen klar ide omkring men der har været en fransk forbindelse s..
20
24 maj
ZEAL
Jeg har nærlæst af briefing dokumentet igår aftes, og stiller mig noget undrende overfor nogle af de..
19
19 maj
OMXC20CAP
Sorry hap - du er en af dem jeg sjælendt bruger tid på at læse. Dine indlæg er såmen ok, jeg er sikk..
15
25 maj
FING-B
Rigtigt mægler - og helt ubegribeligt at derivatmarkedet med dets mange spekulationsformer er tillad..
14
22 maj
BAVA
Du får ikke på puklen af mig, jeg er ligeglad.   Men nu siger jeg det igen, selv om jeg er ret sikke..
14

Sanofi vil smide Medivations bestyrelse på porten

25-05-2016 13:38:02
Det franske medicinalselskab Sanofi, der konkurrerer med blandt andet danske Novo Nordisk, vil have skiftet bestyrelsen i amerikanske Medivation ud for at få en..

Aktier/middag: Novo fortsat i føretrøjen efter amerikansk ja

25-05-2016 11:38:16
Novo Nordisk ligger for anden dag i streg som nummer et i C20 Cap-indekset på Københavns Fondsbørs. Onsdag middag fortsætter medicinalgigantens aktier med at væ..

Aktier/tendens: Entydig positiv start på dagens handel i sigte

25-05-2016 08:44:15
Pilen peger entydigt i positiv retning på det danske aktiemarked onsdag morgen.En stærk afslutning på det amerikanske aktiemarked er fulgt op at solide stigning..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo/Sydbank: Xultophy står umiddelbart stærkere end Lixilan
2
Genmab: Darzalex-salg dykkede med knap 9 pct. i april - NY
3
Aktier/middag: Novo fortsat i føretrøjen efter amerikansk ja
4
Onsdagens aktier: Vestas med i toppen på måske-ordre til Laos
5
Vestas er foretrukken leverandør til kæmpeprojekt i Laos - NY

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
26. maj 2016 04:49:07
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160525.2 - EUROWEB7 - 2016-05-26 04:49:07 - 2016-05-26 04:49:07 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x